Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma
Open Access
- 20 June 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (12) , 10376
Abstract
Melanoma is a highly malignant skin cancer that is known for its resistance to treatments. In recent years, there has been significant progress in the study of non-apoptotic cell death, such as pyroptosis, ferroptosis, necroptosis, and cuproptosis. This review provides an overview of the mechanisms and signaling pathways involved in non-apoptotic cell death in melanoma. This article explores the interplay between various forms of cell death, including pyroptosis, necroptosis, ferroptosis, and cuproptosis, as well as apoptosis and autophagy. Importantly, we discuss how these non-apoptotic cell deaths could be targeted as a promising therapeutic strategy for the treatment of drug-resistant melanoma. This review provides a comprehensive overview of non-apoptotic processes and gathers recent experimental evidence that will guide future research and eventually the creation of treatment strategies to combat drug resistance in melanoma.Keywords
Funding Information
- Wenzhou Municipal Key Laboratory for Applied Biomedical and the Biopharmaceutical Informatics (WB20211227000125, WB20210429000008)
- Zhejiang Bioinformatics International Science and Technology Cooperation Center at Wenzhou-Kean University (WB20211227000125, WB20210429000008)
This publication has 104 references indexed in Scilit:
- Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growthNature Nanotechnology, 2016
- Autophagy promotes ferroptosis by degradation of ferritinAutophagy, 2016
- Absence of RIPK3 predicts necroptosis resistance in malignant melanomaCell Death & Disease, 2015
- Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent mannerCell Death & Disease, 2015
- Cutaneous melanomaThe Lancet, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced MelanomaJournal of Clinical Oncology, 2013
- Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutineBiological Chemistry, 2012
- Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic MelanomaJournal of Clinical Oncology, 2009
- The copper transporter CTR1 provides an essential function in mammalian embryonic developmentProceedings of the National Academy of Sciences, 2001